secwatch.observer — SEC 8-K summary
======================================

Issuer:     NOVAVAX INC (NVAX)
CIK:        0001000694
Form:       8-K
Filed at:   2025-08-21T23:59:59+00:00
Accession:  0001104659-25-081160
Event type: debt
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Novavax issues $225M in 4.625% convertible notes due 2031, refinancing 2027 notes
--------------------------------------------------------------------------------

- Issued $225M of 4.625% Convertible Senior Notes due 2031; exchanged ~$148.7M of 2027 notes and raised ~$49.7M new cash.
- Conversion price $11.14 per share, a 27.5% premium over the Aug 20 closing price of $8.74.
- Approximately $26.5M of 2027 notes remain outstanding; net proceeds from subscription for general corporate purposes.
- Closing expected on or about Aug 27, 2025; financial advisor JWCA plans to buy ~1.2M shares concurrently.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1000694/000110465925081160/0001104659-25-081160-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1000694/000110465925081160/tm2524045d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-081160

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer